http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020153871-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3ea83a47607a771cea1ca020a911e9a5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9521872a273e93af4b35cedd41173cb1 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-70 |
classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-19 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
filingDate | 2019-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54e9cc84e898e8c3e98b87da94dcc677 |
publicationDate | 2020-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | WO-2020153871-A1 |
titleOfInvention | Gene therapy dna vector |
abstract | The invention is related to genetic engineering and can be used in biotechnology, medical science and agriculture to create plant varieties, including transgenic ones. The invention is a gene therapy DNA vector VTvafl7-Actl-Cas9 based on the gene therapy DNA vector VTvaflV carrying the Cas9 therapeutic gene for the heterologous expression of this therapeutic gene in the plant cells during the editing of plant genomes, while the gene therapy DNA vector VTvafl7-Actl-Cas9 has the nucleotide sequence SEQ ID No. 1. The invention can be used in editing of plant genomes in the plant cells. |
priorityDate | 2019-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 99.